U.S. Senator Sanders asks why drug, once free, now costs $375k
WASHINGTON (Reuters) – U.S. Senator Bernie Sanders sent a letter to Catalyst Pharmaceuticals on Monday asking it to justify its decision to charge $ 375,000 annually for a medication that for years has been available to patients for free. U.S. Senator Bernie Sanders speaks during a news conference on Yemen resolution on Capitol Hill in… Read More »